Category Archives: Business and Investments

Latest From Business and Investments

The Value of Partnering Continues to be a Draw for BIO Events

Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia. These meetings allowed industry executives to meet and explore business opportunities with China’s emerging biotech sector. One company in particular, SciClone Pharmaceuticals, invited BioWorld to tag along for the day and get an insider’s look at what a full day of partnering entails. To better understand the full scope of participating in these partnering meetings, read Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Biotech Stocks Hit Record Highs…Again

BIOtech-stocks

Biotech stocks hit an all-time high this week, driven by strong performance among large cap sector leaders with strong product portfolios. A common benchmark for the sector, the NASDAQ Biotechnology Index (NBI) has outperformed the S&P 500 by a factor of over 2X. The NBI is up 61% year to date, compared with 26% for the S&P 500. We’ll be discussing this strong performance in New York this February at the BIO CEO & Investor Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

NYC Launches $100M Life Science Fund

On Tuesday, Deputy Mayor Robert Steel announced that the city is launching the New York City Emerging Life Science Technology Investment Fund, a $100 million venture fund for life sciences research. New York City will invest $10 million along with $40 million from Eli Lilly, Celgene and GE Ventures, with the remaining $50 million matched by venture capital partnerships. The fund will be used to invest in 15-20 early-stage research and development companies by 2020. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Emerging Company Policy Deconstructed: Small Cap Liquidity Reform Act (H.R. 3448)

87881842

In a nutshell: This bill, sponsored by Reps. Sean Duffy (R-WI) and John Carney (D-DE), will spur capital formation by increasing liquidity for emerging growth companies, including biotech innovators, that trade on the public market. Why you should care: Under current U.S. Securities and Exchange Commission (SEC) rules, all securities on the public market are priced in $0.01 increments. This minimum trading increment is known as the “tick size.” The switch to the standard tick Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Emerging Company Policy Deconstructed: Start-up Jobs and Innovation Act (S. 1658)

Cancer

In a nutshell: Senators Robert Menendez (D-NJ) and Pat Toomey (R-PA) introduced the Start-up Jobs and Innovation Act to spur capital formation for R&D-focused companies in the early stages of development. Why you should care: It can take over a decade and cost more than $1 billion to bring a single groundbreaking biotechnology treatment from laboratory bench to hospital bedside, and virtually the entire process is funded by private investment. The Start-up Jobs and Innovation Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,